After years of middling success on the big screen, Apple has bet big on the racecar movie starring Brad Pitt with a budget of nearly $250 million.

Shares in Nike, Inc. (NYSE: NKE) are trading much higher this morning after the company announced its Q4 2025 results. Yet those results saw Nike post some of its worst earnings in a while, along with a warning that President Trump's tariffs would cost the company $1 billion in the near term.

APP's 34X forward P/E may look steep, but strong margins and AXON's ad spend scale help justify the premium.

Buying a stock is easy, but buying the right stock without a good strategy is incredibly hard. Here are five top-performing stocks to buy now or put on a watchlist.

CenterPoint Energy is a Buy, offering stable regulated utility operations and an 8% EPS growth outlook, driven by a $48.5 billion capital plan through 2030. Houston's booming demographics and electric demand create unique, long-term growth tailwinds, supporting continued rate base expansion and earnings visibility. Valuation is in line with peers, but the market underappreciates CenterPoint's superior growth; consensus targets and dividend growth point to further upside.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Peru's state-run oil company Petroperu is in talks with five firms, including Canada's PetroTal and U.S.-based Upland Oil and Gas, as it seeks a partner to reactivate a key Amazon oil block, a company executive said late Thursday.

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”).

BofA Securities analyst Peter T. Galbo reiterated the Buy rating on Primo Brands Corp PRMB, with a price forecast of $42.

Meta is definitely offering hefty multi-million-dollar pay packages to AI researchers when wooing them to its new Superintelligence Lab. But no one is really getting a $100 million “signing bonus,” according to a poached researcher and comments from a leaked internal meeting.

ARM's lofty 85X forward P/E and modest chip royalties raise questions about sustainability amid AI-driven investor hype.

All amounts are in United States dollars, unless otherwise stated. TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) plans to release its second quarter 2025 financial results after market close on Wednesday July 30, 2025.

Titan America operates in a growing industry, but rising supply and capex across the sector raise concerns about future returns and overinvestment. The company's focus on supplementary cementitious materials and its regional presence provide growth opportunities and potential margin stability. Ownership by Titan Cement offers strategic alignment and long-term focus, but also limits minority shareholder influence and adds governance risk.

The expansion aims to enhance the customer experience with expanded cruise portfolio offerings, strengthening JBLU's position as a major tourism partner in all aspects.

The cryptocurrency-trading platform is expected to put up big numbers through 2027 at least.

Nike, Inc.'s fiscal Q4 results were better than feared, signaling early progress but not a full turnaround; the stock rallied on improved sentiment. Management acknowledged past missteps and is refocusing on core franchises, wholesale channels, and innovation with the "sport offense" strategy. Key metrics like inventory stabilization and product traction (e.g., Vomero) are positive, but digital remains weak and China is still a concern.

Retail investors account for a bigger share of trading volume than hedge funds.

Lotus Technology Inc.'s top-line growth is slowing significantly, highlighted by a 46% year-over-year revenue decline in Q1, making revenues unpredictable. With razor-thin gross margins, Lotus is essentially selling cars at cost, preventing any meaningful profit on its core products. The company is hemorrhaging cash, leaving it with dangerously low reserves and unattractive financing options.

Apple made significant changes this week to its App Store terms in Europe. Now regulators will have to sign off.

On Thursday, Altimmune, Inc. ALT released topline results from the IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH).